文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

选择性口腔去污染对ICU获得性多重耐药菌的生态效应:一项5年病例对照研究

Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years.
PubMed 文献 · Intensive Care Med · 2022-08-11
一句话结论在机械通气>48小时患者中,使用选择性口腔去污染与ICU获得性多重耐药菌总体发生率无差异,但产ESBL肺炎克雷伯菌更少、耐万古霉素屎肠球菌更多,且呼吸机相关性肺炎与ICU死亡发生率更低。

该病例对照研究在3个院区11个成人ICU中,分析机械通气>48小时患者使用选择性口腔去污染(SOD)与5年间多重耐药菌(MDRB)发生率及发病密度(每1000患者日)的关系,并按患者来源分层。5034例符合条件,1694例未接受SOD;SOD使用与MDRB总体发病密度无差异,但耐万古霉素屎肠球菌更多(0.72/1000天 vs 0.31/1000天,p<0.01),产ESBL肺炎克雷伯菌更少(0.22/1000天 vs 0.56/1000天,p<0.01)。倾向评分匹配后,SOD与呼吸机相关性肺炎和ICU死亡发生率更低相关,但与ICU获得性菌血症或尿路感染无关。

要点

  • 机械通气>48小时患者使用SOD,MDRB总体发病密度无差异,但耐万古霉素屎肠球菌更多(0.72/1000天 vs 0.31/1000天,p<0.01)。
  • SOD与产ESBL肺炎克雷伯菌发病密度更低相关(0.22/1000天 vs 0.56/1000天,p<0.01)。
  • 倾向评分匹配后,SOD与呼吸机相关性肺炎发生率更低及ICU死亡更低相关。
  • 倾向评分匹配后,SOD与ICU获得性菌血症或尿路感染无显著相关。
  • 研究纳入3个院区11个成人ICU中机械通气>48小时患者,5034例符合条件,1694例未接受SOD。

适用人群与场景

  • 在3个院区11个成人ICU中机械通气>48小时的患者。
  • 按患者来源(门诊或住院)分层分析。

研究设计与关键结果

  • 研究类型为病例对照研究,分析5年间ICU获得性MDRB的长期演变与SOD使用的关系。
  • 共5034例患者符合条件,其中1694例未接受SOD。
  • SOD使用时MDRB总体发病密度无差异,但耐万古霉素屎肠球菌更多(0.72/1000天 vs 0.31/1000天,p<0.01),产ESBL肺炎克雷伯菌更少(0.22/1000天 vs 0.56/1000天,p<0.01)。
  • 倾向评分匹配后,SOD与呼吸机相关性肺炎发生率更低及ICU死亡更低相关,但与ICU获得性菌血症或尿路感染无显著相关。

证据类型、等级与局限

  • 证据类型:病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: This case-control study investigated the long-term evolution of multidrug-resistant bacteria (MDRB) over a 5-year period associated with the use of selective oropharyngeal decontamination (SOD) in the intensive care unit (ICU). In addition, effects on health care-associated infections and ICU mortality were analysed.

METHODS: We investigated patients undergoing mechanical ventilation > 48 h in 11 adult ICUs located at 3 campuses of a university hospital. Administrative, clinical, and microbiological data which were routinely recorded electronically served as the basis. We analysed differences in the rates and incidence densities (ID, cases per 1000 patient-days) of MDRB associated with SOD use in all patients and stratified by patient origin (outpatient or inpatient). After propensity score matching, health-care infections and ICU mortality were compared.

RESULTS: 5034 patients were eligible for the study. 1694 patients were not given SOD. There were no differences in the incidence density of MDRB when SOD was used, except for more vancomycin-resistant Enterococcus faecium (0.72/1000 days vs. 0.31/1000 days, p < 0.01), and fewer ESBL-producing Klebsiella pneumoniae (0.22/1000 days vs. 0.56/1000 days, p < 0.01). After propensity score matching, SOD was associated with lower incidence rates of ventilator-associated pneumonia and death in the ICU but not with ICU-acquired bacteremia or urinary tract infection.

CONCLUSIONS: Comparisons of the ICU-acquired MDRB over a 5-year period revealed no differences in incidence density, except for lower rate of ESBL-producing Klebsiella pneumoniae and higher rate of vancomycin-resistant Enterococcus faecium with SOD. Incidence rates of ventilator-associated pneumonia and death in the ICU were lower in patients receiving SOD.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Wang B, Briegel J, Krueger WA, et al. Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years. Intensive Care Med. 2022. PMID: 35953676. doi:10.1007/s00134-022-06826-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。